Sale!

SLC25A19 Gene Thiamine Metabolism Dysfunction Syndrome 4 Progressive Polyneuropathy Type Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC25A19 Gene Thiamine Metabolism Dysfunction Syndrome 4 Progressive Polyneuropathy Type Genetic Test is a specialized diagnostic procedure designed to identify mutations in the SLC25A19 gene, which are associated with Thiamine Metabolism Dysfunction Syndrome 4 (also known as Progressive Polyneuropathy). This condition is a rare genetic disorder that affects the body’s ability to metabolize thiamine properly, leading to a range of neurological symptoms including progressive polyneuropathy, characterized by the deterioration of nerve function.

The test is crucial for individuals displaying symptoms related to thiamine metabolism dysfunction, as early detection and management can significantly improve the quality of life. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient’s DNA to detect mutations in the SLC25A19 gene that are indicative of the syndrome.

The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. By providing a definitive diagnosis, this genetic test enables healthcare providers to tailor treatment and management plans specifically for the patient’s condition, potentially including thiamine supplementation among other strategies.

Overall, the SLC25A19 Gene Thiamine Metabolism Dysfunction Syndrome 4 Progressive Polyneuropathy Type Genetic Test represents a vital tool in the diagnosis and management of this rare but impactful disorder, offering hope and direction for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC25A19 Gene Thiamine Metabolism Dysfunction Syndrome 4 Progressive Polyneuropathy Type Genetic Test

The SLC25A19 gene is associated with Thiamine Metabolism Dysfunction Syndrome 4 (TMDS4), also known as Progressive Polyneuropathy Type (PPN). This genetic disorder affects the body’s ability to process thiamine (vitamin B1), leading to a deficiency in this essential nutrient.

NGS Genetic Testing, which stands for Next-Generation Sequencing Genetic Testing, is a method used to analyze multiple genes simultaneously. It allows for the detection of genetic variations, including mutations, deletions, or insertions, that may be associated with certain disorders or conditions. In the context of TMDS4 PPN, NGS Genetic Testing can be used to analyze the SLC25A19 gene for any mutations or variations that may be causing the thiamine metabolism dysfunction. This can help in diagnosing the condition and guiding appropriate treatment options.

It’s important to consult with a healthcare professional or a genetic counselor to discuss the specific details of the genetic test, including its purpose, benefits, limitations, and potential implications. They can provide personalized information and guidance based on your individual circumstances.

Test Details

  • Test Name: SLC25A19 Gene Thiamine Metabolism Dysfunction Syndrome 4 Progressive Polyneuropathy Type Genetic Test
  • Components: Blood or Extracted DNA or One drop Blood on FTA Card
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for SLC25A19 Gene Thiamine Metabolism Dysfunction Syndrome 4 Progressive Polyneuropathy Type NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC25A19 Gene Thiamine metabolism dysfunction syndrome 4 progressive polyneuropathy type.
Test Name SLC25A19 Gene Thiamine metabolism dysfunction syndrome 4 progressive polyneuropathy type Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC25A19 Gene Thiamine metabolism dysfunction syndrome 4 progressive polyneuropathy type NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SLC25A19 Gene Thiamine metabolism dysfunction syndrome 4 progressive polyneuropathy type
Test Details

The SLC25A19 gene is associated with Thiamine Metabolism Dysfunction Syndrome 4 (TMDS4), also known as Progressive Polyneuropathy Type (PPN). This genetic disorder affects the body’s ability to process thiamine (vitamin B1), leading to a deficiency in this essential nutrient.

NGS Genetic Testing, which stands for Next-Generation Sequencing Genetic Testing, is a method used to analyze multiple genes simultaneously. It allows for the detection of genetic variations, including mutations, deletions, or insertions, that may be associated with certain disorders or conditions.

In the context of TMDS4 PPN, NGS Genetic Testing can be used to analyze the SLC25A19 gene for any mutations or variations that may be causing the thiamine metabolism dysfunction. This can help in diagnosing the condition and guiding appropriate treatment options.

It’s important to consult with a healthcare professional or a genetic counselor to discuss the specific details of the genetic test, including its purpose, benefits, limitations, and potential implications. They can provide personalized information and guidance based on your individual circumstances.